합성생물학 시장 규모, 점유율, 성장 분석 : 툴별, 용도별, 기술별, 지역별 - 업계 예측(2026-2033년)

Synthetic Biology Market size was valued at USD 17.8 Billion in 2024 and is poised to grow from USD 22.34 Billion in 2025 to USD 137.47 Billion by 2033, growing at a CAGR of 25.5% during the forecast period (2026-2033).

The synthetic biology market is poised for substantial expansion driven by innovations and an increasing demand for sustainable solutions. Rapid advancements in technologies such as Cas9 and CRISPR gene editing, alongside synthetic gene synthesis, enhance the cost-effectiveness and practicality of synthetic biology applications. Heightened interest in creating eco-friendly solutions, including green chemicals, biodegradable materials, and biofuels, is fueled by environmental concerns and the urgent need for sustainability. However, ethical issues and stringent regulatory frameworks concerning genetic modifications and biosafety present challenges to commercialization and research initiatives. Despite these obstacles, the emergence of advanced therapies and personalized medicine holds significant promise for revolutionizing healthcare and addressing previously untreatable conditions, marking a transformative potential for the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Synthetic Biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Synthetic Biology Market Segments Analysis

The global synthetic biology market is segmented by Tool, Application, Technology, and Region. Based on Tool, the market is segmented into Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technologies Kits, Synthetic Cells, Chassis Organisms, and Xeno-Nucleic Acids. Based on Application, the synthetic biology market is segmented into Medical Application, Pharmaceuticals,Drug Discoveryand Therapeutics, Other Medical Application, Artificial Tissue and Tissue Regeneration, Industrial Applications, Other Industries, Food & Agriculture, Environmental Applications. Based on Technology, the market is segmented into Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-directed Mutagenesis, Cloning, Measurement and Modelling, Microfluidics, and Nanotechnology. By Region, the synthetic biology market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Driver of the Synthetic Biology Market

The synthetic biology market is experiencing significant growth driven by advancements in creating innovative therapies, diagnostics, and vaccines, which are enhancing applications in the healthcare and pharmaceutical industries. Additionally, this technology plays a crucial role in developing genetically engineered crops that possess heightened resistance to diseases and pests, thereby contributing to agricultural productivity and bolstering food security. The combination of these transformative capabilities is fostering an increased demand for synthetic biology solutions, ultimately propelling the overall expansion of this market. As various sectors recognize the potential benefits, the influence of synthetic biology continues to expand across diverse applications.

Restraints in the Synthetic Biology Market

The synthetic biology market faces significant challenges due to the high initial costs associated with developing these technologies, which can limit both scalability and accessibility. Additionally, the complexities involved in engineering, designing, and integrating synthetic biology systems can pose considerable obstacles, undermining the overall reliability and efficiency of these innovations. As companies navigate these hurdles, they may encounter constraints that hinder progress and adoption within the industry. Consequently, the financial burden and technical difficulties associated with synthetic biology could stifle growth and investment in this promising yet intricate field, restricting its potential impact on various sectors.

Market Trends of the Synthetic Biology Market

The Synthetic Biology market is witnessing a significant trend towards innovation in epigenetics technologies, as emerging companies recognize the challenges posed by the complex interplay between gene expression, epigenetics, and DNA sequences. The inconsistencies arising from over-activation of synthetic constructs have highlighted the need for more precise and controlled approaches in genetic engineering. New entrants are developing advanced solutions that enable better manipulation of epigenetic factors, thereby enhancing the reliability and predictability of synthetic biology applications. This focus on overcoming epigenetic challenges is poised to drive advancements in various sectors, including agriculture, healthcare, and industrial biotechnology.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Patent Analysis
• Pricing Analysis
• Regulatory Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Synthetic Biology Market by Tool

• Market Overview
• Oligonucleotides and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Synthetic Cells
• Chassis Organisms
• Xeno-nucleic Acids

Synthetic Biology Market by Technology

• Market Overview
• Gene Synthesis
• Genome Engineering
• Sequencing, Bioinformatics
• Site-directed Mutagenesis
• Cloning
• Measurement and Modelling
• Microfluidics
• Nanotechnology

Synthetic Biology Market by Application

• Market Overview

Synthetic Biology Market Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • Italy
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• [if !supportLists] [endif] Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novozymes (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ginkgo Bioworks (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amyris (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precigen, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthetic Genomics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codexis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Enzymes (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bota Biosciences Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enbiotix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pareto Bio, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments